The case of a 35-year-old primigravida with a 21-week intrauterine gestation and concurrent dysgerminoma of the ovary (stage Ic) is presented. A total hysterectomy with bilateral salpingo-oophorectomy was performed, followed by postoperative chemotherapy using cisplatin, bleomycin and vinblastine. The patient has done well since treatment, and is without evidence of recurrent disease 19 months later. Both radiation and chemotherapy are highly effective treatment modalities for dysgerminoma. For those patients with disease presenting in stages Ib, Ic, II and III who wish to maintain fertility, unilateral oophorectomy followed by combination chemotherapy may be curative and spare ovarian function.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Dysgerminomas: germ cell tumors exhibit high expression of PD-L1 and associated with high TILs and good prognosis.
Sci Rep
October 2024
Department of Medical Oncology, King Fahad Specialist Hospital, Eastern Health Cluster, Dammam, Saudi Arabia.
Article Synopsis
- - Ovarian germ cell tumors (OVGCTs) represent 28% of ovarian cancers in Saudi Arabia, with malignant types having a 13% diagnosis rate; patients with recurrent tumors often face a grim prognosis due to aggressive characteristics.
- - This study uniquely investigates PD-L1 expression in OVGCTs, analyzing samples from 34 tumors to understand its role in the tumor microenvironment, immune cell presence, and cancer stem cells' relation to overall clinical outcomes.
- - Results show that dysgerminomas have higher PD-L1 levels than yolk sac tumors, correlating with greater immune cell infiltration and better prognoses, contributing to the potential for immunotherapy in ovarian cancer treatment.
[Gonadoblastoma: Clinicopathological study and literature review of 3 cases].
Zhonghua Nan Ke Xue
July 2023
Department of Pathology, The People's Hospital of Jiangsu Province /The First Affiliated Hospital of Nanjing Medical University, Nanjing， Jiangsu 210029， China.
Article Synopsis
- The study evaluates gonadoblastoma by examining clinical features, pathological morphology, and immunohistochemical characteristics through three patient cases treated between 2014 and 2020.
- The cases involved phenotypical females with varied chromosomal types and presented with specific microscopic features like small nests of primitive germ cells and sex cord-like cells.
- The findings suggest that gonadoblastoma is a rare tumor often linked with gonadal hypoplasia, and the study emphasizes the need for better understanding and accurate diagnosis to avoid misclassifications with similar tumors.
Steroidogenic Acute Regulatory Protein Is a Useful Marker for Sex-Cord-Stroma Tumors and Normal and Neoplastic Adrenocortical Tissue.
Arch Pathol Lab Med
December 2024
From the Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (Lennartz, Amezada, Höflmayer, Dwertmann Rico, von Bargen, Kind, Reiswich, Viehweger, Lutz, Bertram, Fraune, Gorbokon, Weidemann, Hube-Magg, Menz, Uhlig, Krech, Hinsch, Burandt, Sauter, Simon, Kluth, Lebok, Dum, Minner, Jacobsen, Clauditz, Bernreuther, Steurer).
Context.—: Steroidogenic acute regulatory (StAR) protein is a mitochondrial transport protein with a critical regulatory role for steroid hormone production. The tissue distribution of StAR expression is limited to few human normal tissues.
View Article and Find Full Text PDFMalignant ovarian and testicular germ cell tumors: Common characteristics but different prognoses.
J Intern Med
June 2024
Department of Immunology, Genetics and Pathology, Cancer Precision Medicine, Uppsala University, Uppsala, Sweden.
Both ovarian and testicular germ cell tumors (GCTs) arise from the primordial germ cell and share many similarities. Both malignancies affect mainly young patients, show remarkable responsiveness to cisplatin-based therapy, and have an excellent prognosis, which also highlights the importance of minimizing long-term side effects. However, certain differences can be noted: The spreading of the disease differs, and the staging system and treatment recommendations are dissimilar.
View Article and Find Full Text PDFHalf-life of serum anti-Müllerian hormone and changes after gonadectomy in adult female and male dogs with normal and abnormal gonads.
Theriogenology
March 2024
Department of Obstetrics and Food Animal Medicine Clinic, University of Veterinary Medicine Budapest, Hungary; ATRC Aurigon Ltd., Dunakeszi, Hungary. Electronic address:
Anti-Müllerian hormone (AMH) is a biomarker for the presence of gonadal tissue. Changes in serum AMH after gonadectomy are not well established, and its serum half-life is unknown in dogs. We measured serum AMH with a validated electro-chemiluminescent immunoassay in adult female (n = 12) and male (n = 7) dogs with normal gonads, as well as in dogs with gonadal pathology (ovarian remnant syndrome, ORS n = 3, testicular tumor [Leydig cell, Sertoli cell, seminoma] n = 3, unilateral abdominal cryptorchid n = 4) on the day of gonadectomy (D0), and on D3, D7, D14 (females and males), and D21, D28 (males only).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!